The SVP & GC of Ardelyx (ARDX) is Selling Shares


Yesterday, the SVP & GC of Ardelyx (ARDX), Elizabeth Grammer, sold shares of ARDX for $6,400.

Following Elizabeth Grammer’s last ARDX Sell transaction on January 04, 2019, the stock climbed by 0.6%.

See today’s analyst top recommended stocks >>

Currently, Ardelyx has an average volume of 80.11K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts